Search results for "choc"

showing 8 items of 598 documents

The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fr…

2019

Background: Sacubitril/valsartan has been shown to be superior to enalapril in reducing the risks of death and hospitalization for heart failure (HF). However, knowledge of the impact on cardiac performance remains limited. We sought to evaluate the effects of sacubitril/valsartan on clinical, biochemical and echocardiographic parameters in patients with heart failure and reduced ejection fraction (HFrEF). Methods: Sacubitril/valsartan was administered to 205 HFrEF patients. Results: Among 230 patients (mean age 59 &plusmn

medicine.medical_specialtymedicine.medical_treatmentheart failureHemodynamics030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciences0302 clinical medicinehemodynamicInternal medicinemedicineechocardiography030212 general & internal medicineEnalaprilremodelingEjection fractionbusiness.industryneprilysin inhibitionGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareValsartansacubitril/valsartanHeart failureCardiologyreduced ejection fractionDiureticbusinessNt-ProBNPSacubitril Valsartanmedicine.drugJournal of Clinical Medicine
researchProduct

Transesophageal contrast echocardiography is not always the gold standard method in the identification of a patent foramen ovale: A clinical case

2015

In the embryo, Eustachian valve is a crescent-shaped membrane extending from the lower margin of the inferior vena cava and the ostium of the coronary sinus into the right atrium toward fossa ovalis and tricuspid valve. At birth, after the functional closure of the foramen ovale, the Eustachian valve loses its function, reducing to an embryo remnant. According to growing evidence, a persistent Eustachian valve is a frequent finding in patients with a patent foramen ovale (PFO). By directing the blood from the inferior cava to the interatrial septum, it may prevent the spontaneous closure of PFO after birth and indirectly predispose to paradoxical embolism. Transesophageal contrast enhanced …

medicine.medical_specialtypatent foramen ovaleCase ReportInferior vena cavaParadoxical embolismInternal medicineotorhinolaryngologic diseasesmedicineRadiology Nuclear Medicine and imagingFossa ovalisColor Doppler transesophageal echocardiographyForamen ovale (heart)Tricuspid valveEustachian valvebusiness.industrytransesophageal contrast echocardiographymedicine.diseaseEustachian Valvemedicine.anatomical_structuremedicine.veincardiovascular systemCardiologyPatent foramen ovaleCardiology and Cardiovascular MedicinebusinessInteratrial septumJournal of Cardiovascular Echography
researchProduct

The progression rate of aortic stenosis: key to tailoring the management and potential target for treatment

2021

: Aortic stenosis is the most frequent valvular disease to require intervention in the western world and has always been featured as a progressive disease. The rate of progression can be assessed by carefully performed Doppler echocardiography and can vary greatly between individuals with a profound impact on prognosis. Unfortunately, the determinants of disease progression had been insufficiently studied and remain challenging to define, particularly in the outpatient setting. Multiple factors have been proposed and tested, but at present, there are no proven therapies to slow the course of the stenotic process. Heart valve clinics may be particularly important to define the progression ra…

medicine.medical_specialtyprogression rateaortic stenosis degenerative progression rate valvulopathies030204 cardiovascular system & hematologyDoppler echocardiography03 medical and health sciences0302 clinical medicineValvular diseaseRisk FactorsmedicineHumansdegenerative030212 general & internal medicineHeart valveIntensive care medicinemedicine.diagnostic_testbusiness.industryDisease progressionaortic stenosisGeneral MedicineAortic Valve Stenosismedicine.diseasePrognosisvalvulopathiesEchocardiography DopplerStenosismedicine.anatomical_structureaortic stenosis; degenerative; progression rate; valvulopathiesAortic valve stenosisDisease ProgressionProgression rateCardiology and Cardiovascular MedicinebusinessProgressive disease
researchProduct

Longitudinal Strain Analysis and Correlation with TIMI Frame Count in Patients with Ischemia with No Obstructive Coronary Artery (INOCA) and Microvas…

2023

Background: The aim of the study is to evaluate the subclinical alterations of cardiac mechanics detected using speckle-tracking echocardiography and compare these data with the coronary angiography indices used during coronary angiography in a population of patients diagnosed with ischemia with no obstructive coronary artery (INOCA) and microvascular angina (MVA). Methods: The study included 85 patients admitted to our center between November 2019 and January 2022 who were diagnosed with INOCA compared with a control group of 70 healthy patients. A collection of anamnestic data and a complete cardiovascular physical examination, and echocardiogram at rest with longitudinal strain were perf…

microvascular dysfunctionmicrovascular anginaINOCAechocardiographyGeneral Medicineglobal longitudinal strain
researchProduct

Does δ-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?

2009

In this study we clinically and genetically characterize a consanguineous family with a homozygous novel missense mutation in the delta-sarcoglycan gene and a second delta-sarcoglycan mutation that has previously been reported to cause severe autosomal-dominant dilated cardiomyopathy. We identified a novel missense mutation in exon 6 (p.A131P) of the delta-sarcoglycan gene, which in a homozygous state leads to the clinical picture of a limb girdle muscular dystrophy. In four heterozygous carriers for the mutation, aged 3-64 years, a second sequence variant in exon 6 (p.S151A) of the delta-sarcoglycan gene was detected on the other allele. This second missense change had previously been repo…

musculoskeletal diseasesAdultCardiomyopathy DilatedMalemedicine.medical_specialtyAdolescentBiopsyDNA Mutational AnalysisCardiomyopathyMutation MissenseCompound heterozygosityArticleExonConsanguinityElectrocardiographyYoung AdultInternal medicineSarcoglycansGeneticsMedicineMissense mutationHumansMuscular dystrophyChildGenetics (clinical)Genes DominantGeneticsFamily Healthbusiness.industryMusclesMyocardiumDilated cardiomyopathyMiddle Agedmedicine.diseasePedigreeEndocrinologyEchocardiographyChild PreschoolMutation (genetic algorithm)FemalebusinessLimb-girdle muscular dystrophy
researchProduct

Nose-space of dark chocolates using PTR-ToF-MS and link to flavour perception through simultaneous Temporal Dominance of Sensations (TDS)

2018

International audience; Introduction: Aroma of dark chocolate depends on process and cocoa origin and variety. A sensory analysis of 206 standardized chocolates produced from various cocoa beans classified them in four sensory categories. These categories were confirmed in a PTR-MS analysis of the chocolates volatilome [1]. The objective here was to study the nosespace of a subset of chocolates simultaneously with their temporal profile to better explain the sensory categorization at a perception level. Methods: A Temporal Dominance of Sensations (TDS) evaluation of 8 chocolates (2 selected per category) was done in triplicate by 12 subjects while the aroma released in their nose were simul…

nose-space[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[CHIM.ANAL] Chemical Sciences/Analytical chemistry[CHIM.ANAL]Chemical Sciences/Analytical chemistrychocolate[SDV.AEN]Life Sciences [q-bio]/Food and NutritionPTR-MSTDS
researchProduct

KOSMOS 2017 Peru Side Experiment: nutrients, phytoplankton abundances, enzyme rates, photophysiology

2022

This data was collected during an short-term incubation experiment in March 2017 that investigated the response of a surface plankton community to upwelling. This experiment was carried in the framework of the SFB754-funded KOSMOS mesocosm study that took place in La Punta, Callao, Peru between February-April 2017. A total of six different treatments were used to disentangle chemical and biological characteristics of deep water that influence surface plankton blooms: 2 different deep water sources with different nutrient concentrations; 3 treatments to distinguish the effects of inorganic nutrients, organic nutrients and deep water microbial populations. Measured variables include inorganic…

ratioDay of experimentSFB754colored dissolved organic matter at 325 nmNitriteChlorophyll aAbsorption coefficient colored dissolved organic matter at 254 nmClimate - Biogeochemistry Interactions in the Tropical Ocean (SFB754)colorimetric determinationFluorometerFluorometricNitrateNanoplanktonPhytoplankton cells phycocyanin-containing (FL-4)PicoeukaryotesFluorometer fast repetition rateCalculatedFlow cytometryNutrient consumption ratioforward scatterSynechococcusupwelling systemsMesocosm experimentSpectrophotometricClimate Biogeochemistry Interactions in the Tropical Ocean SFB754SilicateBiogeochemistryBiospheric SciencesMaximum photochemical quantum yield of photosystem IIenzyme activitycell sizeDissolved inorganic nitrogen/dissolved inorganic phosphorus ratioKOSMOS_2017chainsAbsorption coefficient colored dissolved organic matter 250 nm/365 nm ratioeastern tropical South Pacific OceanKOSMOSExcess phosphateAbsorption coefficient colored dissolved organic matter at 325 nmNatural SciencesGeosciencescolored dissolved organic matter at 254 nmphycocyanin containing FL 4Absorption coefficientPhosphateTank numberPhytoplankton cells chainsNetwork of Leading European AQUAtic MesoCOSM Facilities Connecting Mountains to Oceans from the ArctReplicatenutrientsfast repetition rateDATE TIMECryptophytesMicrophytoplanktonPhytoplankton cellsLeucine aminopeptidase activityDissolved inorganic nitrogen dissolved inorganic phosphorus ratiofungiEnzymatic assayContinuous flow analyserTreatmentDATE/TIMEcolored dissolved organic matter 250 nm 365 nmPhytoplanktonPhytoplankton cell size forward scatterNetwork of Leading European AQUAtic MesoCOSM Facilities Connecting Mountains to Oceans from the Arctic to the Mediterranean (AQUACOSM)CDOMContinuous flow analyser colorimetric determinationNitrate and Nitrite
researchProduct

Thrombolysis Followed by Apixaban for Massive Pulmonary Embolism and Free-floating Thrombus in Right Ventricle in a Patient with Breast Cancer

2018

Free-floating thrombus in the right ventricle, associated with a massive acute pulmonary embolism (PE), is a rare phenomenon. PE is an important clinical entity with considerable mortality despite advances in diagnosis and treatment. The prognosis of PE depends on right ventricular dysfunction, myocardial injury markers, and early treatment. In this report, we present the case of a 71-year-old woman with a history of breast cancer admitted to intensive care unit for PE complicated by syncope. Although our case may seem complex because it is not represented in the guidelines, the result was satisfactory and showed how treatment with new anticoagulants (in this case apixaban) after massive th…

thrombolysismedicine.medical_specialtymedicine.medical_treatmentCase Reportheparinright ventricle030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineBreast cancerlawInternal medicinemedicineechocardiographyApixabanRadiology Nuclear Medicine and imaging030212 general & internal medicineThrombusbusiness.industrymassive pulmonary embolismThrombolysisHeparinmedicine.diseaseIntensive care unitPulmonary embolismmedicine.anatomical_structureVentricleCardiologyApixabanCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of Cardiovascular Echography
researchProduct